Nigeria: Counterfeit Antimalarials Flood Market

Intelligence from the Nigerian pharmaceutical sector reveals a pervasive influx of counterfeit antimalarial drugs, particularly in the northern and eastern regions. Whistleblowers within distribution channels report that large quantities of fake Artemisinin-based combination therapies (ACTs), often containing no active ingredients or dangerously low doses, are being mass-produced and distributed. The operation is allegedly linked to cross-border smuggling rings that exploit weak enforcement at entry points. This scandal is particularly insidious, as malaria remains a leading cause of death in Nigeria, especially among children. The widespread availability of ineffective counterfeit drugs directly undermines public health efforts and contributes to drug resistance. Manufacturers of genuine antimalarials are also facing significant market share loss. Regulatory bodies are reportedly overwhelmed, and corruption within enforcement agencies is suspected to be facilitating the trade.